Provider 1154674042
Total Paid
$9.6M
$9,607,490
Total Claims
123K
Beneficiaries
76K
1.6 claims/patient
Avg Cost/Claim
$78
Monthly Spending Trend
Yearly Spending
Procedure Breakdown
Cost per claim compared to national benchmarks
This provider bills for 18 distinct procedure codes. The top code (G0481 (Drug test, definitive, 8-14 drug classes)) accounts for 72% of total spending.
$7.0M
56K claims
$123.73
$64.72
Drug test, definitive, 8-14 drug classes
$7.0M
56K claims · 72.4%
$2.3M
49K claims
$46.39
$35.43
Drug test, presumptive, by chemistry analyzers
$2.3M
49K claims · 23.8%
$134K
3,784 claims · 1.4%
$83K
3,461 claims
$24.11
$90.89
Drug test, definitive, 22+ drug classes
$83K
3,461 claims · 0.9%
$57K
3,389 claims · 0.6%
$36K
3,689 claims · 0.4%
$26K
610 claims
$42.49
$37.56
Drug test, definitive, 1-7 drug classes
$26K
610 claims · 0.3%
$15K
488 claims
$30.19
$26.72
Infectious agent detection, nucleic acid, not otherwise specified
$15K
488 claims · 0.2%
$6K
77 claims
$83.43
$60.05
COVID-19 test, nucleic acid detection, CDC lab only
$6K
77 claims · 0.1%
$4K
71 claims
$53.77
$75.26
Drug test, definitive, 15-21 drug classes
$4K
71 claims · 0.0%
$0
241 claims · 0.0%
$0
270 claims · 0.0%
$0
217 claims · 0.0%
$0
202 claims · 0.0%
$0
263 claims
$0.00
$21.08
Trichomonas vaginalis detection, nucleic acid, amplified probe
$0
263 claims · 0.0%
Urinalysis, automated without microscopy
$0
13 claims · 0.0%
$0
243 claims
$0.00
$23.39
Neisseria gonorrhoeae detection, nucleic acid, amplified probe
$0
243 claims · 0.0%
$0
240 claims
$0.00
$24.95
Chlamydia detection, nucleic acid, amplified probe
$0
240 claims · 0.0%